develop a liposome modified with α7 nicotinicacetylcholine eceptors (nAChRs)-binding peptide DCDX to achieve a ‘three birds-one-stone’ delivery strategy, namely, targeting the glioma vessel endothelium, glioma cells, and tumor-associated macrophages that all overexpressing α7 nAChRs (Zheng et al., 2020). This evidence concerns the gene CHRNA7 and glioma.